RAM
GILD icon

Readystate Asset Management’s Gilead Sciences GILD Stock Holding History

Readystate Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,797
Closed -$650K – 729
2025
Q1 		$650K Buy
+5,797
New +$598K 0.02% 426
2024
Q2 		– Sell
-8,360
Closed -$612K – 876
2024
Q1 		$612K Buy
8,360
+6,258
+298% +$481K 0.01% 779
2023
Q4 		$170K Buy
+2,102
New +$164K 0.01% 543

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Readystate Asset Management's GILD Position: Q2 2025 in Review

Readystate Asset Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 5,797 shares — an estimated $650K sold.

Readystate Asset Management first reported a position in GILD in Q4 2023 and held it in 3 quarters. The position peaked at $650K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Readystate Asset Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 5,797 Gilead Sciences shares in Q2 2025, an estimated $650K.
  • Readystate Asset Management first reported a position in Gilead Sciences in Q4 2023 and held it in 3 quarters.
  • Readystate Asset Management's Gilead Sciences position peaked at $650K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.